Interpace Biosciences, Inc. (IDXG)
1.523
-0.09
(-5.42%)
USD |
OTCM |
Aug 21, 16:00
Interpace Biosciences Max Drawdown (5Y) : 96.07% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 96.07% |
| June 30, 2026 | 96.07% |
| May 31, 2026 | 96.07% |
| April 30, 2026 | 96.07% |
| March 31, 2026 | 96.07% |
| February 28, 2026 | 97.75% |
| January 31, 2026 | 97.78% |
| December 31, 2025 | 97.78% |
| November 30, 2025 | 97.78% |
| October 31, 2025 | 97.87% |
| September 30, 2025 | 98.37% |
| August 31, 2025 | 98.64% |
| July 31, 2025 | 98.64% |
| June 30, 2025 | 98.64% |
| May 31, 2025 | 98.64% |
| April 30, 2025 | 98.64% |
| March 31, 2025 | 98.64% |
| February 28, 2025 | 98.64% |
| January 31, 2025 | 98.64% |
| December 31, 2024 | 98.64% |
| November 30, 2024 | 98.64% |
| October 31, 2024 | 98.64% |
| September 30, 2024 | 98.64% |
| August 31, 2024 | 98.64% |
| July 31, 2024 | 98.64% |
| Date | Value |
|---|---|
| June 30, 2024 | 98.64% |
| May 31, 2024 | 98.64% |
| April 30, 2024 | 98.64% |
| March 31, 2024 | 98.73% |
| February 29, 2024 | 98.73% |
| January 31, 2024 | 98.73% |
| December 31, 2023 | 98.73% |
| November 30, 2023 | 98.73% |
| October 31, 2023 | 98.73% |
| September 30, 2023 | 98.73% |
| August 31, 2023 | 98.73% |
| July 31, 2023 | 98.73% |
| June 30, 2023 | 98.73% |
| May 31, 2023 | 98.73% |
| April 30, 2023 | 98.73% |
| March 31, 2023 | 98.73% |
| February 28, 2023 | 98.73% |
| January 31, 2023 | 98.82% |
| December 31, 2022 | 98.82% |
| November 30, 2022 | 98.86% |
| October 31, 2022 | 98.86% |
| September 30, 2022 | 98.86% |
| August 31, 2022 | 98.86% |
| July 31, 2022 | 99.02% |
| June 30, 2022 | 99.02% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Exlites Holdings International, Inc. | 99.86% |
| Xcelerate, Inc. | 95.32% |
| Vivos Therapeutics, Inc. | 99.74% |
| Hinge Health, Inc. | -- |
| PD-Rx Pharmaceuticals, Inc. | 100.0% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -38.86 |
| Beta (5Y) | 0.6126 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.3% |
| Historical Sharpe Ratio (5Y) | -0.3126 |
| Historical Sortino (5Y) | -0.6663 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.42% |